|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-2.71/-0.79
|
企業價值
42.59M
|
資產負債 |
每股賬面淨值
-0.80
|
現金流量 |
現金流量率
--
|
損益表 |
收益
3.13M
|
每股收益
0.14
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/06/01 04:55 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. |